2Swedlow SH,Campo E,Harris NL,et al.World Health Organization Classification of Tumours.Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues[M].IARC Prcss,Lyon,2008.
3Delsol G.M0olecular abnormalities in lymphomas[J].Bull Cancer,2010,97(11):1347-1364.
4Smith SM,Anastasi J,Cohen KS,et al.The impact of MYC expression in lymphoma biology:beyond Burkitl lymphoma[J].Blood CellsMol Dis,2010,45(4):317-323.
5Nakamura S,Byori R.Overview of 2008 WHO Classification of Ma lignant Lymphoma[J].2010,58(11):1105-1111.
4Gonzales F, Abou Chahla W, Pagniez J,et al.Superior vena cava thrombosis in patients with mediastinal large B-cell lymphoma: two pediatric cases[J].Arch Pediatr,2015,22(1):66-70.
5Gebhart J, Lechner K, Skrabs C,et al.Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma [J].Thromb Res, 2014,134(5):980-984.
6Hultcrantz M, Pfeiffer RM, Bjorkholm M,et al.Elevated risk of ve- nous but not arterial thrombosis in Waldenstrom maeroglobulinemi- a/lymphoplasmacytic lymphoma[J].J Thromb Haemost,2014,12(ll): 1816-1821.
